HIPAA Privacy Rule — Updated for 2026 (HIPAA Journal)

Comprehensive HIPAA Journal overview of the HIPAA Privacy Rule updated for 2026. Independent trade publication with established KG precedent (source.hipaajournal-com.hipaa-marketing-rules-2025).

PHI Definition: Protected Health Information (PHI) is "individually identifiable health information" relating to an individual's past, present, or future physical or mental health, provision of healthcare, or payment for healthcare — and that identifies or can reasonably be used to identify the individual. Identifiers only constitute PHI when stored alongside health information in the same record set; when separated, identifiers lose their protected status.

Privacy Rule structure:

• Establishes "federal floor of privacy standards" for covered entities and business associates.
• Permits uses and disclosures only when required by law, authorized by patients, or necessary for treatment, payment, or healthcare operations.
• Applies to covered entities (health plans, healthcare clearinghouses, healthcare providers) and their business associates (including CDP vendors with BAA in place).

Marketing restrictions (CDP-relevant):

• Written authorization required for marketing uses of PHI — the general rule.
• Marketing definition includes any communication about a product or service that encourages purchase/use where the covered entity receives direct or indirect remuneration from a third party.
• Exceptions: communications about health-related products/services provided by or included in the covered entity's own plan of benefits; refill reminders; treatment-related communications; case management.
• Authorizations must disclose any remuneration received; must warn that covered entity cannot control further disclosures if information is published on social media.

2025–2026 context:

• June 18, 2025: U.S. District Court (Northern District of Texas) vacated most of the HIPAA Privacy Rule to Support Reproductive Health Care Privacy (2024 Final Rule). Compliance required for remaining NPP modifications by February 16, 2026.

Relevance to KG:

• Grounds constraint.hipaa-phi-cdp-healthcare (TC-34) with Privacy Rule marketing restriction content.
• Supports use-case.hipaa-safe-performance-marketing (OC-008) framework for PHI consent and BAA requirements.
• Complements source.hipaajournal-com.hipaa-marketing-rules-2025 with broader Privacy Rule scope.
• Note: HHS primary regulatory text (hhs.gov) remains inaccessible at Tier 1–2; this Tier 1 hipaajournal.com source provides secondary-level grounding. Confidence cap applies for rubric scoring to ≥ 0.85 threshold.